| Name |
Santen Pharmaceutical Co., Ltd. |
Corporate
Headquarters
|
9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku,
Osaka 533-8651, Japan
Map
to Head Office
TEL: +81-6-6321-7000
FAX: +81-6-6328-5082 |
| Established |
1890 |
| Incorporated |
1925 |
| Paid-in Capital |
6,418 million yen |
Number of
Employees
|
2,483 (non-consolidated: 1,847) |
| Representatives |
Takakazu Morita (Chairman)
Akira Kurokawa (President & CEO)
|
Stock Exchange
Listings
|
Tokyo and Osaka
(Stock code: 4536)
|
| Business |
Research and development, production and marketing
of pharmaceuticals and medical devices
|
Offices,
Laboratories
and Plants
|
Nara Research and Development Center, Noto
Plant, Shiga Plant, Osaka Plant, approx.80 Marketing Offices in Japan (Tokyo Office,
etc.), Beijing Representative Office and Guangzhou Representative Office
See
Global
Operations
for details. |
| Subsidiaries |
Japan:
Claire Co., Ltd., etc.
International:
Santen Inc. (US), Santen Oy (Finland), etc.
See
Global Operations
for details. |
Back to top
|
|
|
